Drug−Protein Adducts: An Industry Perspective on Minimizing the Potential for Drug Bioactivation in Drug Discovery and Development
Year: 2003
Type: review
Source: Chemical Research in Toxicology
DOI: 10.1021/tx034170b
Authors: David C. Evans, Alan P. Watt, Deborah A. Nicoll-Griffith, Thomas A. Baillie
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2101016189